Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we look at the new administration’s choice for interim DEA head. Florida may have cannabis on the ballot in 2026. Leafly is off the NASDAQ. And finally, we bid farewell to Janet Yellen.
Continue Reading The Week in Weed: January 24, 2025The Week in Weed: January 17, 2025
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we give you an update on the DEA re-scheduling hearing. Spoiler alert: it ain’t happening. We also check in with Virginia, to see what the legislature has planned for legalization, and how the governor feels about those plans. It’s been a while since we had news from Nebraska, so we’ll look at what the Cornhusker State is up to. And finally, if you’re looking for an alcohol replacement during Dry January, some folks are turning to cannabis.
Continue Reading The Week in Weed: January 17, 2025Re-scheduling in Limbo – Hearing Cancelled
Drug Enforcement Administration (DEA) Administrative Law Judge (ALJ) John Mulrooney has cancelled the long-awaited cannabis re-scheduling hearing set for next week. Pro-reform advocates have suggested that the DEA had improper communications with re-scheduling opponents, and filed a request for leave to file an interlocutory appeal. ALJ Mulrooney granted this request and has stayed proceedings for at least 90 days. Next week also brings a new administration, which, together with other ongoing litigation concerning the hearings, could add a layer of complexity to the situation.
Further bulletins as events warrant!
The Week in Weed: January 10, 2025
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. New York released updated cannabis industry data. The Congressional Cannabis Caucus has new leadership. Wisconsin’s governor calls for a ballot initiative on adult-use. The DEA faces charges of improper conduct surrounding re-scheduling. And finally, Cher reflects on Sonny’s anti-marijuana stance.
Continue Reading The Week in Weed: January 10, 2025The Week in Weed: January 3, 2025
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. Last week, we looked back at 2024; this week we look forward to 2025. Where will cannabis be legalized? What’s the outlook for the industry? What about banking or rescheduling? So many questions…
Continue Reading The Week in Weed: January 3, 2025The Saga Continues: Fifth Circuit Court Reinstates Nationwide Injunction on CTA Pausing FinCEN’s Recently Announced Reporting Deadlines
For insights on the latest developments related to the CTA, visit Seyfarth’s Corporate Transparency Act newsroom.
What You Need to Know
Earlier this week, the Financial Crimes Enforcement Network (FinCEN) of the U.S. Department of the Treasury reset Corporate Transparency Act (CTA) reporting deadlines. However, on December 26, 2024, the Fifth Circuit Court of Appeals issued a new order vacating a stay, effectively reinstating the nationwide preliminary injunction. As a result, the reporting requirements of the CTA – that is, requirements to report BOI – are once again enjoined nationwide, and enforcement remains suspended pending further proceedings. Accordingly, the new filing deadlines recently announced by FinCEN appear to no longer be applicable for the time being, but we continue to monitor developments.
Continue Reading The Saga Continues: Fifth Circuit Court Reinstates Nationwide Injunction on CTA Pausing FinCEN’s Recently Announced Reporting DeadlinesThe Year in Weed: 2024 Edition
Welcome back to The Year In Weed, The Blunt Truth’s annual roundup of cannabis-related stories. As usual, I’ll adopt Dave Barry’s Year in Review (sadly, no longer available for free) format and look at stories month by month. Last year, I hoped that the feds, New York and Alabama would get their acts together, as I was running out of metaphors to describe their respective situations. Did that holiday dream come true? Well…
Continue Reading The Year in Weed: 2024 EditionThe Week in Weed: December 20, 2024
Welcome back to the Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we check in on Nebraska, of course. We also report on the situation with Minnesota’s licensing lottery. We have some information on the proposal in Texas to ban THC. And finally, we pass along a job ad.
Continue Reading The Week in Weed: December 20, 2024The Week in Weed: December 13, 2024
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we consider changing the name of this column to “The Broken Record Report,” as we provide updates on, you guessed it, DEA re-scheduling and the Nebraska ballot initiative. We’ll throw in some news on SAFER Banking and Mitch McConnell – if you think you know where this is going, you’re right. And finally, we note that Massachusetts is considering an expansion to the number of places where cannabis can be consumed.
Continue Reading The Week in Weed: December 13, 2024Upcoming Webinar: Navigating Marijuana Law for Employers: Compliance, Testing, and Policy Essentials
Navigating Marijuana Law for Employers: Compliance, Testing, and Policy Essentials
Thursday, December 19th, Seyfarth attorneys Jennifer Mora and Fritz Smith will present a webinar Navigating Marijuana Law for Employers: Compliance, Testing, and Policy Essentials.
Thursday, December 19, 2024
1:00 p.m. to 2:00 p.m. Eastern
12:00 p.m. to 1:00 p.m. Central
11:00 a.m. to 12:00 p.m. Mountain
10:00 a.m. to 11:00 a.m. Pacific
About the Program
Medical and recreational marijuana laws continue to sweep the nation, leaving many employers wondering how their current hiring and drug testing practices might be affected.
In this webinar, we will review which marijuana laws impact employers and discuss key areas on which employers need to focus when it comes to staying compliant in the evolving legal landscape.
Topics include:
- An overview of THC testing methodologies
- The current state of marijuana at the federal level
- State and local medical and recreational marijuana laws
- Drug testing considerations, including unique state policy requirements
- Issues for regulated employers (e.g., DOT and government contractors)